Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.19 USD | +4.25% | -6.73% | -27.17% |
Apr. 17 | Eton Pharmaceuticals, Inc. cancelled the transaction announced on April 15, 2024 | CI |
Apr. 15 | Eton Pharmaceuticals, Inc. announced that it expects to receive $13.125 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.17% | 78.61M | |
+10.08% | 9.12B | |
-17.63% | 4.8B | |
+0.73% | 3.8B | |
+16.55% | 3.72B | |
+27.76% | 2.58B | |
-26.11% | 2.36B | |
-30.09% | 2.11B | |
+7.15% | 1.86B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- Eton Pharmaceuticals Adds FDA-Approved Rare Disease Product to Metabolic Genetics Portfolio